Details of the Drug Reposition

General Information of This Drug (ID: DM19A89)

Drug Name
Androgen   DM19A89
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Prostate cancer DISF190Y 2C82.0 Approved [1]
------------------------------------------------------------------------------------
2 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cryptorchidism DISYUD2P N.A. Withdrawn [2]
Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome DISZOS19 N.A. Withdrawn [3]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Klinefelter syndrome DISOUI7W N.A. Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hypogonadism, male DISV1F5R N.A. Investigative [5]
------------------------------------------------------------------------------------

References

1 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
2 Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
3 Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
4 A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)
5 Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications. Curr Pharm Des. 2017;23(30):4475-4483.